In a recent achievement, DP Technology's hit discovery platform RiDYMO® has successfully designed a cyclic peptide targeting β-catenin, a historically 'undruggable' protein, in just two months. This ...

Umbrella Labs has expanded its range of compounds, providing a wider selection of refined options to support research across various scientific fields. This increased variety includes ...